Maintaining an open environment that creates space for their employees to balance family and work life is among the key factors highlighted by Jason Borschow, President of Abarca, and Mercibel González, VP of Talent Strategy, as drivers of the company’s selection as one of the top ten Best Employers on the island for the second […]
Design Articles
Abarca named #3 Best Employer by Kincentric: We work for our Abarcans
October 5th, 2021 by Abarca NewsAbarca earns top scores on Kincentric’s Global Employee Engagement Survey
October 4th, 2021 by Abarca NewsSAN JUAN, PR — Abarca, a pharmacy benefit manager (PBM) that is disrupting the industry with a new approach to technology and business practices, has earned top scores on a global employee engagement survey from Kincentric, an international HR and talent advisory firm. Based on these results, Abarca has also been named among the top […]
Abarca renews, expands partnerships for pharmacy benefit services with Triple-S, CareFirst
September 30th, 2021 by GabrielleSan Juan (September 30, 2021) – Abarca, a pharmacy benefit manager (PBM) that is disrupting the industry with a new approach to technology and business practices, today announced that it has renewed agreements with two Blue Cross Blue Shield Association member plans. Triple-S Management Corporation (NYSE: GTS) renewed its contract for PBM services on behalf of […]
Jason Borschow qualified as an Endeavor Outlier
September 24th, 2021 by GabrielleSAN JUAN, PR — Jason Borschow, President and CEO of Abarca, has qualified as an Endeavor Outlier, an exclusive global group of high-impact entrepreneurs from the prestigious Endeavor, a global network with the mission of unlocking the transformational power of entrepreneurship by selecting, supporting and investing in the world’s top founders and providing them a platform to […]
What you need to know: COVID-19 booster shots versus additional doses
September 20th, 2021 by Abarca NewsAt present, much talk has been circulating as to whether booster shots or additional doses for the COVID-19 vaccine are necessary, safe, or effective. As part of our mission to bring better care to our communities through education and the latest updates in current health trends and topics, in this blog, we explore the difference […]
Triple-S and Abarca renew, expand partnership for pharmacy benefit services
September 15th, 2021 by GabrielleSAN JUAN, PR — Abarca, a pharmacy benefit manager (PBM) that is disrupting the industry with a new approach to technology and business practices, today announced that Triple-S Management Corporation (NYSE: GTS) renewed its contract for PBM services on behalf of its managed care subsidiary, Triple-S Salud. This three-year agreement applies to the company’s Medicare […]
“Insourcing: the future of pharmacy benefits” with Javier González at the 2021 PBMI Annual National Conference
September 14th, 2021 by Abarca NewsToday, more than 85% of the PBM market is controlled by three companies that happen to be owned by very large health plans. This puts other payers in a position where they are partnering with–and turning control over their pharmacy benefits to a large and formidable competitor. Those who are averse to this type of […]
A vaccine for Parkinson’s Disease?
August 30th, 2021 by GabrielleLast year, the first data was published from a clinical trial evaluating a vaccine for Parkinson’s Disease. While the multi-year study was relatively small, the results could be big for the healthcare industry and millions of people around the world who might someday benefit from the vaccine. Here’s what you need to know: What is […]
Introducing Abarca’s new pharmacy portal
August 19th, 2021 by Abarca UserPharmacists and their teams play a critical role in member health. However, making a meaningful impact requires access to advanced tools and timely resources. That’s why Abarca has launched a brand new pharmacy portal. This convenient, centralized, one-stop platform will simplify the day-to-day operations for healthcare providers–while giving them resources to help deliver a better […]
Aduhelm 101: What you need to know about the new Alzheimer’s drug
August 17th, 2021 by GabrielleThis summer, Aduhelm became the first Alzheimer’s medication to receive FDA approval in nearly 20 years. However, it was met with controversy from across the healthcare industry and beyond. Here is what you need to know: What is Aduhelm? Aduhelm (aducanumab-avwa) is a drug developed by pharmaceutical manufacturers Biogen and Eisai to treat Alzheimer’s Disease. […]